Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00615
|
|||||
| Drug Name |
Chenodeoxycholic acid
|
|||||
| Synonyms |
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid; (3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid; 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol; 3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid; 3,7-Dihydroxycholan-24-oic acid; 3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid; 3-alpha,7-beta-Dihydroxycholanic acid; 3-alpha,7-beta-Dioxycholanic acid; 3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid; 3alpha,7beta-Dihydroxy-5beta-cholanic acid; 5beta-Cholan-24-oic acid-3alpha,7beta-diol; 5beta-Cholanic Acid-3alpha,7beta-diol; 7-beta-Hydroxylithocholic acid; 7beta-Hydroxylithocholic acid; Acide ursodesoxycholique; Acide ursodesoxycholique [INN-French]; Acido ursodeossicolico; Acido ursodeossicolico [Italian]; Acido ursodeoxicolico; Acido ursodeoxicolico [INN-Spanish]; Acidum ursodeoxycholicum; Acidum ursodeoxycholicum [INN-Latin]; Actigall; Actigall (TN); Antigall; Arsacol; Chenodeoxycholic acid; Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-(9CI); Cholit-ursan; Delursan; Deoxyursocholic Acid; Destolit; Deursil; Deursil (TN); Dom-ursodiol c; ISO-URSODEOXYCHOLIC ACID; IU5; Litursol; Lyeton; PHL-ursodiol c; PMS-ursodiol c; Peptarom; Sodium Ursodeoxycholate; Solutrat; U-9000; U0030; UDCA;UDCS; UrSO; Urosiol; Ursacholic Acid; Ursacol; Urso (TN); Urso 250; Urso DS; Urso Forte; Urso Forte (TN); Ursobilin; Ursochol; Ursodamor; Ursodeoxy cholic acid; Ursodeoxycholate; Ursodeoxycholic acid (JP15/INN); Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol; Ursodesoxycholicacid; Ursodexycholic Acid; Ursodiol; Ursodiol (USP); Ursodiol [USAN]; Ursofalk; Ursolvan; Ursosan; Ursosan (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Primary biliary cirrhosis [ICD11: DB96.1] | Approved | [1] | |||
| Therapeutic Class |
Cholagogues and Choleretics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H40O4
|
|||||
| Canonical SMILES |
CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
|
|||||
| InChI |
InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
|
|||||
| InChIKey |
RUDATBOHQWOJDD-UZVSRGJWSA-N
|
|||||
| CAS Number |
CAS 128-13-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 392.6 | Topological Polar Surface Area | 77.8 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
4.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10082
, 102851587
, 103578669
, 103913836
, 104169985
, 104253279
, 104310778
, 11433256
, 11466986
, 11468106
, 11486841
, 11532904
, 121362367
, 121363593
, 124757400
, 124800594
, 125085062
, 125164204
, 14718187
, 14756614
, 14780856
, 24900651
, 29204656
, 3138790
, 34673541
, 46508795
, 47193720
, 47217051
, 47515582
, 47885649
, 48110725
, 48185236
, 48416690
, 49699224
, 49748670
, 49902961
, 50124074
, 53788379
, 57311214
, 78337565
, 7847799
, 7850921
, 7888488
, 7980868
, 8172159
, 822713
, 87577760
, 92125922
, 92717068
, 99431529
|
|||||
| ChEBI ID |
ChEBI:9907
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [2] | |
| References | ||||||
| 1 | Chenodeoxycholic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3. J Lipid Res. 2006 Jun;47(6):1196-202. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.